Oncology Drug Development and Dose Optimization: What Are the Implications of Project Optimus?
1:05:36
Project Optimus – FDA’s New Dose Optimization & Selection Paradigm in Oncology Drug Development
41:52
Immune-Based Intratumoral Cancer Therapies ft. Intensity Therapeutics founder and CEO Lewis Bender
59:00
What is FDA Project Optimus and How Will it Impact Oncology Drug Development?
11:02
What Does it Take to Change the Way We Manage Pain?
56:57
Beyond Accelerated Approvals: External Control Arms
4:41
What Makes Oncology Clinical Trials Unique From Others? - A Clinical Research Site Perspective
1:28:43
Modeling and Simulation to Select Oncology Dosages - Session 1
59:30